Symbols / XRAY Stock $11.91 +0.08% DENTSPLY SIRONA Inc.

Healthcare • Medical Instruments & Supplies • United States • NMS
XRAY (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Daniel T. Scavilla
Exch · Country NMS · United States
Market Cap 2.39B
Enterprise Value 4.51B
Income -598.00M
Sales 3.68B
FCF (ttm) 106.38M
Book/sh 6.71
Cash/sh 1.77
Employees 14,000
Insider 10d —
IPO Aug 12, 1987
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 28.83%
P/E —
Forward P/E 7.68
PEG 0.83
P/S 0.65
P/B 1.78
P/C —
EV/EBITDA 7.55
EV/Sales 1.22
Quick Ratio 0.81
Current Ratio 1.51
Debt/Eq 185.00
LT Debt/Eq —
EPS (ttm) -3.00
EPS next Y 1.55
EPS Growth —
Revenue Growth 6.20%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-05
Earnings (prior) 2026-02-26
ROA 2.74%
ROE -36.43%
ROIC —
Gross Margin 50.00%
Oper. Margin 1.77%
Profit Margin -16.25%
Shs Outstand 200.32M
Shs Float 188.84M
Insider Own 0.49%
Instit Own 109.43%
Short Float 11.31%
Short Ratio 5.46
Short Interest 20.31M
52W High 17.18
vs 52W High -30.68%
52W Low 9.85
vs 52W Low 20.91%
Beta 1.00
Impl. Vol. 63.28%
Rel Volume 0.59
Avg Volume 4.45M
Volume 2.63M
Target (mean) $14.10
Tgt Median $14.00
Tgt Low $10.00
Tgt High $18.00
# Analysts 15
Recom Hold
Prev Close $11.90
Price $11.91
Change 0.08%
About

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$14.10
Mean price target
2. Current target
$11.91
Latest analyst target
3. DCF / Fair value
$9.56
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$11.91
Low
$10.00
High
$18.00
Mean
$14.10

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-15 init Citigroup — → Sell $10
2026-03-02 main Mizuho Neutral → Neutral $16
2026-03-02 main Barrington Research Outperform → Outperform $17
2026-02-27 main Wells Fargo Equal-Weight → Equal-Weight $13
2026-02-27 main Evercore ISI Group In-Line → In-Line $15
2026-02-27 main Baird Neutral → Neutral $14
2026-02-19 up B of A Securities Neutral → Buy $17
2026-02-03 main UBS Buy → Buy $16
2026-01-20 main Mizuho Neutral → Neutral $14
2026-01-05 main Barrington Research Outperform → Outperform $14
2025-12-16 main Barrington Research Outperform → Outperform $14
2025-12-16 main Baird Neutral → Neutral $12
2025-12-09 init Barclays — → Underweight $12
2025-11-10 main Barrington Research Outperform → Outperform $14
2025-11-07 main JP Morgan Neutral → Neutral $12
2025-11-07 main Wells Fargo Equal-Weight → Equal-Weight $12
2025-11-07 down William Blair Outperform → Market Perform —
2025-10-29 main Barrington Research Outperform → Outperform $18
2025-10-28 main UBS Buy → Buy $23
2025-10-08 main Evercore ISI Group In-Line → In-Line $13
News
RSS: Latest XRAY news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-09 LUCIER GREGORY T Director — 15,000 $12.44 $186,675
2026-03-09 FORBES JAMES D Director — 5,000 $12.48 $62,400
2026-03-04 JOHNSON ROBERT ANTHONY Officer — 44,643 $0.00 $0
2026-03-04 CZERNEY KEVIN J. Officer — 13,690 $0.00 $0
2026-03-04 DENTI ALDO MARIANO ROBERTO Officer — 59,524 $0.00 $0
2026-03-04 SCAVILLA DANIEL T Chief Executive Officer — 145,089 $0.00 $0
2026-03-04 FROHNING ANDREA L Officer — 26,786 $0.00 $0
2026-03-03 LUCIER GREGORY T Director — 50,000 $14.03 $707,379
2026-03-03 FORBES JAMES D Director — 5,000 $13.47 $67,345
2026-03-02 JOHNSON ROBERT ANTHONY Officer — 9,599 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
3,680.00
-2.98%
3,793.00
-4.34%
3,965.00
+1.10%
3,922.00
Operating Revenue
3,680.00
-2.98%
3,793.00
-4.34%
3,965.00
+1.10%
3,922.00
Cost Of Revenue
1,840.00
+0.27%
1,835.00
-2.34%
1,879.00
+4.68%
1,795.00
Reconciled Cost Of Revenue
1,840.00
+0.27%
1,835.00
-2.34%
1,879.00
+4.68%
1,795.00
Gross Profit
1,840.00
-6.03%
1,958.00
-6.14%
2,086.00
-1.93%
2,127.00
Operating Expense
1,588.00
-10.28%
1,770.00
-1.50%
1,797.00
+1.93%
1,763.00
Research And Development
150.00
-9.09%
165.00
-10.33%
184.00
+5.75%
174.00
Selling General And Administration
1,438.00
-10.40%
1,605.00
-0.50%
1,613.00
+1.51%
1,589.00
General And Administrative Expense
—
—
1,620.00
+1.50%
1,596.00
Salaries And Wages
—
—
7.00
+0.00%
7.00
Other Gand A
—
—
1,613.00
+1.51%
1,589.00
Total Expenses
3,428.00
-4.91%
3,605.00
-1.93%
3,676.00
+3.32%
3,558.00
Operating Income
252.00
+34.04%
188.00
-34.95%
289.00
-20.60%
364.00
Total Operating Income As Reported
-422.00
+51.99%
-879.00
-934.12%
-85.00
+90.93%
-937.00
EBITDA
-46.00
+91.12%
-518.00
-308.03%
249.00
+137.61%
-662.00
Normalized EBITDA
596.00
+12.88%
528.00
-14.84%
620.00
-3.88%
645.00
Reconciled Depreciation
352.00
+0.86%
349.00
+1.75%
343.00
+4.57%
328.00
EBIT
-398.00
+54.09%
-867.00
-822.34%
-94.00
+90.51%
-990.00
Total Unusual Items
-642.00
+38.62%
-1,046.00
-181.94%
-371.00
+71.61%
-1,307.00
Total Unusual Items Excluding Goodwill
-642.00
+38.62%
-1,046.00
-181.94%
-371.00
+71.61%
-1,307.00
Special Income Charges
-674.00
+36.83%
-1,067.00
-185.29%
-374.00
+71.25%
-1,301.00
Impairment Of Capital Assets
650.00
-35.90%
1,014.00
+230.29%
307.00
-76.15%
1,287.00
Restructuring And Mergern Acquisition
24.00
-54.72%
53.00
-20.90%
67.00
+378.57%
14.00
Net Income
-598.00
+34.29%
-910.00
-589.39%
-132.00
+86.11%
-950.00
Pretax Income
-486.00
+48.08%
-936.00
-434.86%
-175.00
+83.41%
-1,055.00
Net Non Operating Interest Income Expense
-88.00
-27.54%
-69.00
+14.81%
-81.00
-24.62%
-65.00
Interest Expense Non Operating
88.00
+27.54%
69.00
-14.81%
81.00
+24.62%
65.00
Net Interest Income
-88.00
-27.54%
-69.00
+14.81%
-81.00
-24.62%
-65.00
Interest Expense
88.00
+27.54%
69.00
-14.81%
81.00
+24.62%
65.00
Other Income Expense
-650.00
+38.39%
-1,055.00
-175.46%
-383.00
+71.71%
-1,354.00
Other Non Operating Income Expenses
-8.00
+11.11%
-9.00
+25.00%
-12.00
-9.09%
-11.00
Gain On Sale Of Security
32.00
+52.38%
21.00
+600.00%
3.00
+150.00%
-6.00
Gain On Sale Of Business
—
—
0.00
+100.00%
-3.00
Tax Provision
112.00
+530.77%
-26.00
+39.53%
-43.00
+59.05%
-105.00
Tax Rate For Calcs
0.00
+650.00%
0.00
-88.60%
0.00
+148.20%
0.00
Tax Effect Of Unusual Items
-134.82
-360.33%
-29.29
+67.87%
-91.16
+29.55%
-129.39
Net Income Including Noncontrolling Interests
-598.00
+34.29%
-910.00
-589.39%
-132.00
+86.11%
-950.00
Net Income From Continuing Operation Net Minority Interest
-598.00
+34.29%
-910.00
-589.39%
-132.00
+86.11%
-950.00
Net Income From Continuing And Discontinued Operation
-598.00
+34.29%
-910.00
-589.39%
-132.00
+86.11%
-950.00
Net Income Continuous Operations
-598.00
+34.29%
-910.00
-589.39%
-132.00
+86.11%
-950.00
Minority Interests
0.00
0.00
0.00
0.00
Normalized Income
-90.82
-185.11%
106.71
-27.82%
147.84
-35.05%
227.61
Net Income Common Stockholders
-598.00
+34.29%
-910.00
-589.39%
-132.00
+86.11%
-950.00
Diluted EPS
-3.00
+33.04%
-4.48
-622.58%
-0.62
+85.94%
-4.41
Basic EPS
-3.00
+33.04%
-4.48
-622.58%
-0.62
+85.94%
-4.41
Basic Average Shares
199.40
-1.87%
203.20
-4.15%
212.00
-1.62%
215.50
Diluted Average Shares
199.40
-1.87%
203.20
-4.15%
212.00
-1.62%
215.50
Diluted NI Availto Com Stockholders
-598.00
+34.29%
-910.00
-589.39%
-132.00
+86.11%
-950.00
Earnings From Equity Interest
—
—
-4.00
+88.89%
-36.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
5,429.00
-5.63%
5,753.00
-21.94%
7,370.00
-3.57%
7,643.00
Current Assets
2,023.00
+15.86%
1,746.00
-11.51%
1,973.00
+4.23%
1,893.00
Cash Cash Equivalents And Short Term Investments
326.00
+19.85%
272.00
-18.56%
334.00
-8.49%
365.00
Cash And Cash Equivalents
326.00
+19.85%
272.00
-18.56%
334.00
-8.49%
365.00
Receivables
737.00
+21.62%
606.00
-19.84%
756.00
+10.36%
685.00
Accounts Receivable
688.00
+23.74%
556.00
-20.00%
695.00
+9.97%
632.00
Gross Accounts Receivable
700.00
+22.81%
570.00
-19.94%
712.00
+10.22%
646.00
Allowance For Doubtful Accounts Receivable
-12.00
+14.29%
-14.00
+17.65%
-17.00
-21.43%
-14.00
Taxes Receivable
49.00
-2.00%
50.00
-18.03%
61.00
+15.09%
53.00
Inventory
642.00
+13.83%
564.00
-9.62%
624.00
-0.48%
627.00
Raw Materials
199.00
+15.70%
172.00
-7.03%
185.00
+9.47%
169.00
Work In Process
82.00
+13.89%
72.00
-6.49%
77.00
+0.00%
77.00
Finished Goods
361.00
+12.81%
320.00
-11.60%
362.00
-4.99%
381.00
Prepaid Assets
168.00
+11.26%
151.00
+3.42%
146.00
+14.06%
128.00
Other Current Assets
150.00
-1.96%
153.00
+35.40%
113.00
+28.41%
88.00
Total Non Current Assets
3,406.00
-15.00%
4,007.00
-25.76%
5,397.00
-6.14%
5,750.00
Net PPE
1,000.00
+10.86%
902.00
-7.77%
978.00
+1.77%
961.00
Gross PPE
2,572.00
+14.67%
2,243.00
-4.27%
2,343.00
+3.08%
2,273.00
Accumulated Depreciation
-1,572.00
-17.23%
-1,341.00
+1.76%
-1,365.00
-4.04%
-1,312.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
52.00
+13.04%
46.00
-6.12%
49.00
+2.08%
48.00
Buildings And Improvements
638.00
+11.73%
571.00
+0.53%
568.00
+4.03%
546.00
Machinery Furniture Equipment
1,609.00
+14.68%
1,403.00
-0.50%
1,410.00
+3.45%
1,363.00
Construction In Progress
134.00
+54.02%
87.00
-36.96%
138.00
+18.97%
116.00
Other Properties
139.00
+2.21%
136.00
-23.60%
178.00
-11.00%
200.00
Goodwill And Other Intangible Assets
2,122.00
-24.32%
2,804.00
-32.32%
4,143.00
-9.76%
4,591.00
Goodwill
1,148.00
-28.12%
1,597.00
-34.50%
2,438.00
-9.30%
2,688.00
Other Intangible Assets
974.00
-19.30%
1,207.00
-29.21%
1,705.00
-10.40%
1,903.00
Other Non Current Assets
284.00
-5.65%
301.00
+9.06%
276.00
+39.39%
198.00
Total Liabilities Net Minority Interest
4,089.00
+7.32%
3,810.00
-6.53%
4,076.00
+6.40%
3,831.00
Current Liabilities
1,343.00
-15.48%
1,589.00
+11.51%
1,425.00
+21.79%
1,170.00
Payables And Accrued Expenses
590.00
-4.22%
616.00
-21.73%
787.00
+7.51%
732.00
Payables
330.00
+15.38%
286.00
-20.56%
360.00
+8.76%
331.00
Accounts Payable
300.00
+24.48%
241.00
-20.98%
305.00
+9.32%
279.00
Current Accrued Expenses
260.00
-21.21%
330.00
-22.72%
427.00
+6.48%
401.00
Pensionand Other Post Retirement Benefit Plans Current
171.00
+10.32%
155.00
—
—
Total Tax Payable
30.00
-33.33%
45.00
-18.18%
55.00
+5.77%
52.00
Income Tax Payable
30.00
-33.33%
45.00
-8.16%
49.00
+6.52%
46.00
Current Debt And Capital Lease Obligation
360.00
-39.50%
595.00
+57.41%
378.00
+119.77%
172.00
Current Debt
313.00
-42.99%
549.00
+70.50%
322.00
+172.88%
118.00
Other Current Borrowings
231.00
+66.19%
139.00
+43.30%
97.00
+321.74%
23.00
Current Capital Lease Obligation
47.00
+2.17%
46.00
-17.86%
56.00
+3.70%
54.00
Current Deferred Liabilities
74.00
-22.11%
95.00
+4.40%
91.00
+8.33%
84.00
Current Deferred Revenue
74.00
-22.11%
95.00
+4.40%
91.00
+8.33%
84.00
Other Current Liabilities
30.00
+150.00%
12.00
-33.33%
18.00
-5.26%
19.00
Total Non Current Liabilities Net Minority Interest
2,746.00
+23.64%
2,221.00
-16.22%
2,651.00
-0.38%
2,661.00
Long Term Debt And Capital Lease Obligation
2,108.00
+25.70%
1,677.00
-12.70%
1,921.00
-2.73%
1,975.00
Long Term Debt
2,015.00
+27.05%
1,586.00
-11.69%
1,796.00
-1.64%
1,826.00
Long Term Capital Lease Obligation
93.00
+2.20%
91.00
-27.20%
125.00
-16.11%
149.00
Non Current Deferred Liabilities
94.00
-27.13%
129.00
-43.42%
228.00
-20.56%
287.00
Non Current Deferred Taxes Liabilities
94.00
-27.13%
129.00
-43.42%
228.00
-20.56%
287.00
Other Non Current Liabilities
544.00
+31.08%
415.00
-17.33%
502.00
+25.81%
399.00
Stockholders Equity
1,339.00
-31.05%
1,942.00
-41.03%
3,293.00
-13.59%
3,811.00
Common Stock Equity
1,339.00
-31.05%
1,942.00
-41.03%
3,293.00
-13.59%
3,811.00
Capital Stock
3.00
+0.00%
3.00
+0.00%
3.00
+0.00%
3.00
Common Stock
3.00
+0.00%
3.00
+0.00%
3.00
+0.00%
3.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
264.50
+0.00%
264.50
+0.00%
264.50
-0.04%
264.60
Ordinary Shares Number
199.60
+0.40%
198.80
-4.05%
207.20
-3.76%
215.30
Treasury Shares Number
64.90
-1.22%
65.70
+14.66%
57.30
+16.23%
49.30
Additional Paid In Capital
6,644.00
+0.06%
6,640.00
-0.05%
6,643.00
+0.21%
6,629.00
Retained Earnings
-1,564.00
-87.31%
-835.00
-507.32%
205.00
-55.04%
456.00
Gains Losses Not Affecting Retained Earnings
-639.00
+12.47%
-730.00
-14.78%
-636.00
-1.27%
-628.00
Treasury Stock
3,105.00
-0.99%
3,136.00
+7.32%
2,922.00
+10.31%
2,649.00
Minority Interest
1.00
+0.00%
1.00
+0.00%
1.00
+0.00%
1.00
Other Equity Adjustments
-639.00
+12.47%
-730.00
-14.78%
-636.00
-1.27%
-628.00
Total Equity Gross Minority Interest
1,340.00
-31.03%
1,943.00
-41.01%
3,294.00
-13.59%
3,812.00
Total Capitalization
3,354.00
-4.93%
3,528.00
-30.67%
5,089.00
-9.72%
5,637.00
Working Capital
680.00
+333.12%
157.00
-71.35%
548.00
-24.20%
723.00
Invested Capital
3,667.00
-10.06%
4,077.00
-24.65%
5,411.00
-5.98%
5,755.00
Total Debt
2,468.00
+8.63%
2,272.00
-1.17%
2,299.00
+7.08%
2,147.00
Net Debt
2,002.00
+7.46%
1,863.00
+4.43%
1,784.00
+12.98%
1,579.00
Capital Lease Obligations
140.00
+2.19%
137.00
-24.31%
181.00
-10.84%
203.00
Net Tangible Assets
-783.00
+9.16%
-862.00
-1.41%
-850.00
-8.97%
-780.00
Tangible Book Value
-783.00
+9.16%
-862.00
-1.41%
-850.00
-8.97%
-780.00
Commercial Paper
82.00
-80.00%
410.00
+82.22%
225.00
+136.84%
95.00
Current Provisions
118.00
+1.72%
116.00
-23.18%
151.00
-7.36%
163.00
Interest Payable
44.00
+450.00%
8.00
-11.11%
9.00
+0.00%
9.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
235.00
-49.02%
461.00
+22.28%
377.00
-27.08%
517.00
Cash Flow From Continuing Operating Activities
235.00
-49.02%
461.00
+22.28%
377.00
-27.08%
517.00
Net Income From Continuing Operations
-598.00
+34.29%
-910.00
-589.39%
-132.00
+86.11%
-950.00
Depreciation Amortization Depletion
352.00
+0.86%
349.00
+1.75%
343.00
+4.57%
328.00
Depreciation
141.00
+6.02%
133.00
+0.76%
132.00
+10.92%
119.00
Amortization Cash Flow
211.00
-2.31%
216.00
+2.37%
211.00
+0.96%
209.00
Depreciation And Amortization
352.00
+0.86%
349.00
+1.75%
343.00
+4.57%
328.00
Amortization Of Intangibles
211.00
-2.31%
216.00
+2.37%
211.00
+0.96%
209.00
Other Non Cash Items
-10.00
-11.11%
-9.00
-550.00%
2.00
-96.67%
60.00
Stock Based Compensation
33.00
-15.38%
39.00
-15.22%
46.00
-22.03%
59.00
Asset Impairment Charge
650.00
-35.90%
1,014.00
+230.29%
307.00
-76.15%
1,287.00
Deferred Tax
30.00
+122.06%
-136.00
-4.62%
-130.00
+42.98%
-228.00
Deferred Income Tax
30.00
+122.06%
-136.00
-4.62%
-130.00
+42.98%
-228.00
Operating Gains Losses
—
19.00
+733.33%
-3.00
-107.69%
39.00
Gain Loss On Sale Of PPE
0.00
-100.00%
19.00
+733.33%
-3.00
-200.00%
3.00
Change In Working Capital
-222.00
-333.68%
95.00
+269.64%
-56.00
+28.21%
-78.00
Change In Receivables
-91.00
-187.50%
104.00
+279.31%
-58.00
-168.24%
85.00
Changes In Account Receivables
—
—
-58.00
-168.24%
85.00
Change In Inventory
-17.00
-200.00%
17.00
+183.33%
6.00
+104.26%
-141.00
Change In Prepaid Assets
-7.00
-118.42%
38.00
+165.52%
-58.00
-75.76%
-33.00
Change In Payables And Accrued Expense
-63.00
+8.70%
-69.00
-322.58%
31.00
+29.17%
24.00
Change In Accrued Expense
-74.00
-89.74%
-39.00
-329.41%
17.00
+383.33%
-6.00
Change In Payable
11.00
+136.67%
-30.00
-314.29%
14.00
-53.33%
30.00
Change In Account Payable
11.00
+136.67%
-30.00
-314.29%
14.00
-53.33%
30.00
Change In Other Working Capital
-32.00
-184.21%
38.00
+445.45%
-11.00
+26.67%
-15.00
Change In Other Current Assets
-7.00
-40.00%
-5.00
-225.00%
4.00
+300.00%
1.00
Change In Other Current Liabilities
-5.00
+82.14%
-28.00
-193.33%
30.00
+2900.00%
1.00
Investing Cash Flow
-132.00
+32.99%
-197.00
-121.35%
-89.00
+35.51%
-138.00
Cash Flow From Continuing Investing Activities
-132.00
+32.99%
-197.00
-121.35%
-89.00
+35.51%
-138.00
Net PPE Purchase And Sale
—
—
7.00
0.00
Sale Of PPE
—
—
7.00
0.00
Capital Expenditure
-131.00
+27.22%
-180.00
-20.81%
-149.00
+0.00%
-149.00
Capital Expenditure Reported
-131.00
+27.22%
-180.00
-20.81%
-149.00
+0.00%
-149.00
Net Investment Purchase And Sale
-4.00
+63.64%
-11.00
-128.21%
39.00
+200.00%
13.00
Purchase Of Investment
-14.00
-16.67%
-12.00
0.00
0.00
Sale Of Investment
10.00
+900.00%
1.00
-97.44%
39.00
+200.00%
13.00
Net Business Purchase And Sale
0.00
0.00
-100.00%
13.00
0.00
Purchase Of Business
—
—
0.00
0.00
Gain Loss On Sale Of Business
—
—
0.00
-100.00%
3.00
Net Other Investing Changes
3.00
+150.00%
-6.00
-175.00%
8.00
+500.00%
-2.00
Financing Cash Flow
-80.00
+73.51%
-302.00
+1.63%
-307.00
+6.69%
-329.00
Cash Flow From Continuing Financing Activities
-80.00
+73.51%
-302.00
+1.63%
-307.00
+6.69%
-329.00
Net Issuance Payments Of Debt
70.00
-22.22%
90.00
-24.37%
119.00
+298.33%
-60.00
Issuance Of Debt
988.00
+455.06%
178.00
+41.27%
126.00
+2000.00%
6.00
Repayment Of Debt
-918.00
-943.18%
-88.00
-1157.14%
-7.00
-250.00%
-2.00
Long Term Debt Issuance
553.00
+55200.00%
1.00
0.00
-100.00%
6.00
Long Term Debt Payments
-147.00
-67.05%
-88.00
-1157.14%
-7.00
-250.00%
-2.00
Net Long Term Debt Issuance
406.00
+566.67%
-87.00
-1142.86%
-7.00
-275.00%
4.00
Short Term Debt Issuance
435.00
+145.76%
177.00
+40.48%
126.00
—
Short Term Debt Payments
-771.00
0.00
0.00
+100.00%
-64.00
Net Short Term Debt Issuance
-336.00
-289.83%
177.00
+40.48%
126.00
+296.88%
-64.00
Net Common Stock Issuance
0.00
+100.00%
-250.00
+16.67%
-300.00
-100.00%
-150.00
Common Stock Payments
0.00
+100.00%
-250.00
+16.67%
-300.00
-100.00%
-150.00
Common Stock Dividend Paid
—
—
—
—
Cash Dividends Paid
-128.00
-1.59%
-126.00
-8.62%
-116.00
-11.54%
-104.00
Repurchase Of Capital Stock
0.00
+100.00%
-250.00
+16.67%
-300.00
-100.00%
-150.00
Proceeds From Stock Option Exercised
—
—
0.00
-100.00%
6.00
Net Other Financing Charges
-22.00
-37.50%
-16.00
-60.00%
-10.00
+33.33%
-15.00
Changes In Cash
23.00
+160.53%
-38.00
-100.00%
-19.00
-138.00%
50.00
Effect Of Exchange Rate Changes
31.00
+229.17%
-24.00
-100.00%
-12.00
+50.00%
-24.00
Beginning Cash Position
272.00
-18.56%
334.00
-8.49%
365.00
+7.67%
339.00
End Cash Position
326.00
+19.85%
272.00
-18.56%
334.00
-8.49%
365.00
Free Cash Flow
104.00
-62.99%
281.00
+23.25%
228.00
-38.04%
368.00
Interest Paid Supplemental Data
66.00
-27.47%
91.00
-6.19%
97.00
+38.57%
70.00
Income Tax Paid Supplemental Data
71.00
-4.05%
74.00
-58.19%
177.00
+45.08%
122.00
Earnings Losses From Equity Investments
—
0.00
-100.00%
4.00
-88.89%
36.00
Sale Of Business
0.00
0.00
-100.00%
13.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category